(PharmaNewsWire.Com, May 09, 2019 ) Breast cancer is the most common form cancer in women. Breast cancer is majorly characterized by the development of lumps in the breast, inverted nipple, a change in breast shape, fluid coming from the nipple, or a red or scaly patch of skin, dimpling of the skin and breast pain or sore nipple. Mastectomy is a procedure for the treatment of breast cancer that includes removal of entire breast through a surgical process.
Breast reconstruction surgery is used to rebuild the breasts after mastectomy. Implant reconstruction and autologous or flap reconstruction are the two key techniques for breast reconstruction surgery. In the recent years, many women are opting for reconstruction procedures to regain the original shape of their breasts after the mastectomy. This increasing preference is expected to boost the market growth in the coming years.
Insulet Corporation Medtronic Tandem Diabetes Care, Inc Debiotech S.A CELLNOVO SOOIL Developments Co., Ltd MicroPort Scientific Corporation Valeritas Inc. Hoffmann-La Roche Ltd. Ypsomed AG Market Segmentation
Type Insights
The global Breast Reconstruction market by type was led by tube pumps segment. In 2017, the pumps segment held a largest market share of 85.7% of the Breast Reconstruction market, by type. The segment is also expected to dominate the market in 2025, since pump helps in delivering precise amount of insulin to the body than any other insulin delivery devices.
Product Insights
The global Breast Reconstruction market by product was led by pumps segment. In 2017, the pumps segment held a largest market share of 76.8% of the Breast Reconstruction market, by product. The segment is also expected to dominate the market in 2025, since they offer are used in the diabetes management for the administering of continues fast acting insulin in the body.
Application Insights
The Breast Reconstruction market by application was segmented into type I diabetes and type II diabetes. The type I diabetes segment held the largest share of the market, by application. The segment is also likely to dominate during the forecast period, due to increase in the cases of type I diabetes among individuals, mostly in the developed nations.
The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We are a specialist in Technology, Healthcare, Manufacturing, Automotive and Defense.
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including:
